Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer

PURPOSE: The combination of chemotherapy and trastuzumab is the standard of care for adjuvant treatment of human epidermal growth factor receptor 2–positive breast cancer. Two regimens have been widely adopted in the United States: doxorubicin, cyclophosphamide, paclitaxel, and trastuzumab (ACTH) an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Oncol
Hauptverfasser: Reeder-Hayes, Katherine E., Meyer, Anne Marie, Hinton, Sharon Peacock, Meng, Ke, Carey, Lisa A., Dusetzina, Stacie B.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2017
Schlagworte:
ORIGINAL REPORTS
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652869/
https://ncbi.nlm.nih.gov/pubmed/28727517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.4345
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge